Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
228.82
-2.95 (-1.27%)
At close: Jul 2, 2024, 4:00 PM
230.50
+1.68 (0.73%)
After-hours: Jul 2, 2024, 5:45 PM EDT
Biogen Employees
Biogen had 7,570 employees as of December 31, 2023. The number of employees decreased by 1,155 or -13.24% compared to the previous year.
Employees
7,570
Change (1Y)
-1,155
Growth (1Y)
-13.24%
Revenue / Employee
$1,276,499
Profits / Employee
$154,108
Market Cap
33.32B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7,570 | -1,155 | -13.24% |
Dec 31, 2022 | 8,725 | -885 | -9.21% |
Dec 31, 2021 | 9,610 | 510 | 5.60% |
Dec 31, 2020 | 9,100 | 1,700 | 22.97% |
Dec 31, 2019 | 7,400 | -400 | -5.13% |
Dec 31, 2018 | 7,800 | 500 | 6.85% |
Dec 31, 2017 | 7,300 | -100 | -1.35% |
Dec 31, 2016 | 7,400 | 50 | 0.68% |
Dec 31, 2015 | 7,350 | -200 | -2.65% |
Dec 31, 2014 | 7,550 | 700 | 10.22% |
Dec 31, 2013 | 6,850 | 900 | 15.13% |
Dec 31, 2012 | 5,950 | 950 | 19.00% |
Dec 31, 2011 | 5,000 | 150 | 3.09% |
Dec 31, 2010 | 4,850 | 100 | 2.11% |
Dec 31, 2009 | 4,750 | 50 | 1.06% |
Dec 31, 2008 | 4,700 | 400 | 9.30% |
Dec 31, 2007 | 4,300 | 550 | 14.67% |
Dec 31, 2006 | 3,750 | 410 | 12.28% |
Dec 31, 2005 | 3,340 | -926 | -21.71% |
Dec 31, 2004 | 4,266 | 539 | 14.46% |
Feb 20, 2004 | 3,727 | 2,732 | 274.57% |
Jan 31, 2003 | 995 | 303 | 43.79% |
Jan 31, 2002 | 692 | 199 | 40.37% |
Jan 31, 2001 | 493 | 86 | 21.13% |
Jan 31, 2000 | 407 | 42 | 11.51% |
Jan 31, 1999 | 365 | 26 | 7.67% |
Dec 31, 1997 | 339 | 71 | 26.49% |
Dec 31, 1996 | 268 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
IQVIA Holdings | 87,000 |
Centene | 67,000 |
GE HealthCare Technologies | 51,000 |
ICON PLC | 41,100 |
Haleon | 25,408 |
Agilent Technologies | 18,100 |
Mettler-Toledo International | 17,300 |
ResMed | 10,140 |
BIIB News
- 1 hour ago - Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Accesswire
- 1 hour ago - Biogen Inc. Class Action: Levi & Korsinsky Reminds Biogen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2024 – BIIB - Accesswire
- 1 hour ago - BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit - PRNewsWire
- 7 hours ago - Biogen Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - BIIB - Accesswire
- 7 hours ago - Investors who lost money on Biogen Inc.(BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB - Accesswire
- 7 hours ago - The Schall Law Firm Encourages Biogen Inc Investors Who Have Sustained Losses To Make Contact Be Mindful Of The Deadline In This Situation - Accesswire
- 8 hours ago - Lost Money on Biogen Inc. (BIIB)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Accesswire
- 8 hours ago - Biogen Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB - Accesswire